Dr. Hans Klingemann is the chief science officer at ImmunityBio, which develops immunotherapy drugs for people. He also explores whether the treatments might someday prolong dogs’ lives.
Cuts in the cranium, which is more than 4,000 years old, hint that people in the ancient civilization attempted to treat a scourge that persists today.
At an industry presentation about dangerous “forever chemicals,” lawyers predicted a wave of lawsuits that could dwarf asbestos litigation, audio from the event revealed.
A new analysis of dozens of studies has identified the most common warning symptoms in adults under 50, whose rates of colon and rectal cancer are on the rise.
Martha Warren, 65, of Westerly, R.I., found out last year that she had small cell lung cancer, and joined the tarlatamab clinical trial. She said she now feels as good as before her diagnosis.
Login
